Inflamma­tory Brain Disorders
Conference 2022

Hosted by Neuroimmune Foundation
and accredited in collaboration with
The Wisconsin Medical Society

May 20 – 21, 2022

A live CME event via webinar

9:00 am – 5:30 pm CT each day

Registration is closed.

Confirmed 2022 Speakers

Please find all information on speaker biographies and presentation summaries in our

Lawrence Steinman, MD

Professor of Neurology and Pediatrics, Stanford University School of Medicine, Keynote Speaker

Does Molecular Mimicry Explain Epidemiology Linking EBV & MS? Oligoclonal Antibody in MS Cerebrospinal Fluid Binds EBNA-1 and GlialCAM

Sean Pittock, MD

Director, Center for Multiple Sclerosis and Autoimmune Neurology and Neuroimmunology Research Laboratory, Mayo Clinic

GAD65 Neurological Autoimmunity

Sarosh Irani, FRCP DPhil FEAN

Associate Professor, University of Oxford; Head of Autoimmune Neurology Group, University of Oxford

The Immunology Underlying Autoantibody Associated CNS Diseases

Robert Yolken, MD

Professor of Neurovirology in Pediatrics, Johns Hopkins University School of Medicine

Neuropsychiatric Consequences of Viral Infections – Focus on SARS-CoV-2 and Other Coronaviruses

Michael Wilson, MD

Distinguished Professor of Neurology, University of California, San Francisco (UCSF)

Autoimmune and Infectious Encephalitis

Emily Severance, PhD

Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine

Autoimmune Phenotypes in Psychiatric Disorders

Jenny Frankovich, MD, MS

Clinical Professor of Pediatrics, Rheumatology, Stanford University School of Medicine; Director, Stanford PANS Research Program

Evidence for PANS as an Inflammatory Brain Disorder

Mark Pasternack, MD

Chief of Pediatric Infectious Disease,
Associate Professor of Pediatrics, Massachusetts General Hospital, Harvard

Use of Antibiotics in Infection Associated Neuropsychiatric Syndromes Including PANS

Charles Raison, MD

Professor of Psychiatry, University of Wisconsin

Inflammation in the Development and Treatment of Depression

Jonas Bergquist, MD, PhD

Professor in Analytical Chemistry and Neurochemistry, Department of Chemistry, Uppsala University, Sweden; Adjunct Professor in Pathology, University of Utah School of Medicine; Distinguished Professor in Precision Medicine, Binzhou Medical University, China

Chronic Fatigue Syndrome / Myalgic Encephalomyelitis

Shannon Delaney, MD

Assistant Professor of Psychiatry, Columbia University Irving Medical Center, Director, Child and Adolescent Evaluation, Lyme & Tick-borne Disease Research Center, Columbia University Medical Center

Neuropsychiatric Illness Associated with Lyme and Tick-borne Illness

Sandeep Vaishnavi, MD, PhD

Adjunct Associate, Department of Medicine, Duke University School of Medicine; Neuropsychiatrist, Faculty, Duke Institute of Brain Sciences

Use of TMS in OCD

Janet Cunningham, MD, PhD

Associate Professor, Department of Neuroscience, Associate Professor in Experimental Psychiatry, Uppsala University, Sweden

Clinical and Biological Heterogeneity in an Adult Patient Cohort with Psychiatric Symptoms Enriched for Suspected Immunological Involvement

Brent T. Harris, MD, PhD, FCAP

Associate Professor of Pathology and Neurology, Georgetown University School of Medicine; Director, Georgetown Brain Bank

The Neuropathology of Autoimmune Encephalitis and PANS and Development of Specialized Brain Banks for These Disorders

Sarkis Mazmanian, PhD

Professor of Microbiology, California Institute of Technology; Investigator, Heritage Medical Research Institute

Development of Microbiome-Based Therapeutics for Autism

Sameer Sheth, MD, PhD

Associate Professor of Neurosurgery, Psychiatry & Behavioral Sciences, and Neuroscience; Director, Psychiatric Neurosurgery, Cullen Foundation Endowed Chair, Baylor College of Medicine

Neuromodulation for Psychiatric Disorders

Wanjun Chen, MD

Senior Investigator, Chief, Mucosal Immunology Section, NIDCR, NIH

Regulatory T Cells for Immunotherapy of Neurological Autoimmunity

Meiqian Ma, MD

Clinical Professor, Pediatrics, Rheumatology, Stanford University School of Medicine

Arthritis, Enthesitis, and Development of Autoimmune/Inflammatory Disease in Patients with PANS

Shreyas Vasanawala, MD, PhD

Division Chief of Pediatric Radiology, Associate Chair of Radiology; Radiologist-in-Chief for Pediatric Radiology, Stanford

Arthritis, Enthesitis, and Development of Autoimmune/Inflammatory Disease in Patients with PANS

Agnieszka Kalinowski, MD

Clinical Instructor, Psychiatry and Behavioral Sciences, Stanford University School of Medicine

C4B Gene Copy in Children With PANS

Chandra Menendez, PhD

Postdoctoral Research Fellow, Microbiology & Immunology, University of Oklahoma Health Sciences Center

A New Look: Autoantibodies Against the Dopamine Receptors Define PANDAS and Sydenham Chorea

Naresha Saligrama, PhD

Assistant Professor of Neurology, Washington University in St. Louis; Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

T cells and Neurodegeneration

Cheri Standing, MD

Pediatrician, Greater Regional Health

PANS Cases: Through the Eyes of a Pediatrician

Margo Thienemann, MD

Clinical Professor, Psychiatry, Stanford University School of Medicine; Director Stanford PANS Clinic

PTSD in Caregivers of Children with PANS

Elizabeth Mellins, MD

Professor of Pediatrics, Pediatric Rheumatologist and Molecular Immunologist, Stanford University School of Medicine

Evidence for PANS as an Inflammatory Brain Disorder

Learning and Outcome Objectives

  • Learn how to effectively treat inflammatory brain conditions as well as the circumstances in which each treatment is appropriate.
  • Learn the clinical work up required to accurately diagnose immune mediated causes of neurologic and psychiatric deteriorations.
  • Recognize that neuropsychiatric  sequelae can result from infections, autoimmune, and inflammatory conditions.
  • Accurately diagnose various inflammatory brain conditions.
  • Describe appropriate treatments for patients with inflammatory brain conditions.
  • Identify the various immune and inflammatory markers that can present in patients with inflammatory brain conditions.
  • Report the cognitive and psychiatric effects seen in some patients following COVID-19.

Accreditation / Credit Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wisconsin Medical Society and Neuroimmune Foundation. The Wisconsin Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

The Wisconsin Medical Society designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accommodations

Neuroimmune Foundation subscribes to the articles of Title III of the Americans with Disabilities Act of 1990. Should you or anyone accompanying you require special assistance, please notify us by contacting conference@neuroimmune.org or 608-381-0367. Requests should be made as early as possible to allow time to arrange the accommodation.

Physician Comments from 2021 Inflammatory Brain Disorders Conference

“This is the most comprehensive, well-organized, and current information on all topics I have encountered in such a long time. I plan to attend every conference moving forward. Thank you for such well-presented information. Armed with several screenshots of slides, I have already contacted several patients to complete a more thorough history for a more complete treatment plan. So grateful.”
Maria Del Sol, MD
Child and Adolescent Psychiatrist, Florida

“The neuroimmune conference transformed my thinking about the relationship between infection, neurobiology and psychiatric disorders. I learned so much.”
Melissa Aguirre, MD
Pediatrician, California

“This conference had the highest scientific quality and rigor, and all the presenters and discussants were outstanding. The contribution of the foundation for children with neuroimmune disorders to society is incommensurable.”
Rosa Aurora Chavez, MD, PhD, FABP
Washington, DC

“This was a conference with fantastic collaborators and speakers. As a physician I felt that it was clinically oriented and cutting edge. It was incredibly useful to gain knowledge in a field like neuroimmunology where so little is known.”
Anuja Vyas, MD, FACOG
Texas

“As a clinical psychiatrist, it is crucial that I understand the potential origins of psychiatric symptoms. This conference gave insight into infectious and immune mechanisms for Neuropsychiatric symptoms that I found truly valuable. The speakers were of top quality.”
Matthew Bernstein, MD
Psychiatrist, Massachusetts

“I was astounded by the amount of scientifically based data presented on encephalopathy, COVID and PANS/PANDAS at this conference. I thought all of the presenters at this conference did an excellent job explaining the pathophysiology involved in the various conditions that were highlighted in this conference.”

Urszula Kotlow, MD
Pediatric Psychiatrist, CPAE Clinic, Banner Desert Medical Center, Arizona

“I feel more confident as THE consultant on many of these cases due to expanded knowledge I have acquired via this resource. Excellent presentations with fantastic evidence-based information. I hope to be involved in more conferences. Thanks to all!”
Sandra Lawrence, MD, FACR
Pediatric Rheumatology, Florida

Registration is closed.